Announcements Trials
Browse Landscape

Phase

Phase 1/2 2

Status

Terminated 1Active not recruiting 1

Sponsor Class

OTHER 55NIH 15INDUSTRY 9NETWORK 2UNKNOWN 1OTHER_GOV 1

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 11Sarcoma 9Gynecologic 7Genitourinary 7Lymphoid 6Other hematologic neoplasm 5Breast 5Head & Neck 4Gastrointestinal 3Thoracic 2

Conditions

Carcinoma, Non-Small-Cell Lung 2Neoplasms 1Lung Neoplasms 1

Interventions

Cisplatin 40Carboplatin 40Paclitaxel 34Radiotherapy 32Docetaxel 19Pemetrexed 17Gemcitabine 17Etoposide 17Bevacizumab 11Radiosurgery 9Magnetic Resonance Spectroscopy 9Ramucirumab 8durvalumab 7Taxes 7Cetuximab 7pembrolizumab 6Specimen Handling 6Erlotinib Hydrochloride 6Irinotecan 5Gene Expression Profiling 5Filgrastim 5cediranib 4Vinorelbine 4Polymerase Chain Reaction 4Neoadjuvant Therapy 4Fluorodeoxyglucose F18 4Chemotherapy, Adjuvant 4Amplified Fragment Length Polymorphism Analysis 4tremelimumab 3osimertinib 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × Radiation × Thoracic × Clear all
NCT02764086 2026-04-13

INTENSE: A Phase I/II Study of INhomogeneous Targeted Dose Escalation in Non-Small CEll Lung Cancer

Cancer Trials Ireland

Phase 1/2 Terminated
6 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT01770418 2025-09-09

A Phase I/II Study of Hypofractionated Proton Therapy for Stage II-III Non-Small Cell Lung Cancer

Proton Collaborative Group

Phase 1/2 Active not recruiting
32 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡